JAAD-D-22-01027
Published: 31 August 2022| Version 2 | DOI: 10.17632/244yhvtxsz.2
Contributor:
QIAN ZHAODescription
Supplemental Materials and Methods for "Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study".
Files
Categories
Dermatomyositis